glp-1 receptor function agonists for individualized treatment of type 2 diabetes mellitus GLP-1 receptor agonists and next-generation

Franzman, M.R., Burnell, K.K., Dehkordi-Vakil, F.H., Guthmiller, J.M., Dawson, D.V., and Brogden, K.A., Int

Abnormal coordination, ataxia, confusion, abnormal thinking, agitation, amnesia, anxiety, depersonalization, depression, emotional lability, euphoria, impaired concentration, insomnia, sleep disorders, nervousness, paroniria, dysphonia, asthenia, malaise, pain, hyperesthesia, hypoesthesia, hyperkinesia, hypertonia, migraine headache, myelitis, paralysis, paresthesia, ptosis, syncope, tremor, twitching, and vertigo have been reported in less than 2% of patients 12 years of age and older and children 6-11 years of age receiving cetirizine hydrochloride

From that point, the frequency drops to every other day for seven doses

This should be combined with other approaches for sustained weight management and metabolic health